GLENMARK LIFE SCIENCES
Back to Cashflow Statement
|
GLENMARK LIFE SCIENCES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-279 Cr | ₹-388 Cr | ₹-79 Cr | ₹-214 Cr | ₹-137 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLENMARK LIFE SCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-279 Cr |
Mar2023 | ₹-388 Cr |
Mar2022 | ₹-79 Cr |
Mar2021 | ₹-214 Cr |
Mar2020 | ₹-137 Cr |
How is Cash Flow from Financing Activities of GLENMARK LIFE SCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-279 Cr | Negative | |
Mar2023 | ₹-388 Cr | Negative | |
Mar2022 | ₹-79 Cr | Negative | |
Mar2021 | ₹-214 Cr | Negative | |
Mar2020 | ₹-137 Cr | - |
Compare Cash Flow from Financing Activities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹12,504.8 Cr | -2% | 0.2% | 32.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -3.7% | -2.5% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | 2.3% | 2.1% | 46.9% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.2% | 0% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -2.4% | 7.3% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | 2% | 2.3% | 37.9% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -2% |
0.2% |
32.2% |
SENSEX | -2.2% |
-5.9% |
7.2% |
You may also like the below Video Courses